Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CXCR2/IL-8RB Antibody (48311) [DyLight 350], Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals FAB331D

Catalog No. NB372567


Only null left
Add to Cart

Description

Description

CXCR2/IL-8RB Monoclonal antibody specifically detects CXCR2/IL-8RB in Human samples. It is validated for Flow Cytometry, Immunohistochemistry, Neutralization, CyTOF
Specifications

Specifications

CXCR2/IL-8RB
Monoclonal
DyLight 350
50mM Sodium Borate
Mouse
Protein A or G purified from ascites
RUO
Primary
Human
Purified
Flow Cytometry, Immunohistochemistry, Neutralization, CyTOF
48311
Flow Cytometry, Immunohistochemistry, Neutralization, CyTOF-ready
CD182 antigen, CDw128b, chemokine (C-X-C motif) receptor 2, chemokine (CXC) receptor 2, C-X-C chemokine receptor type 2, CXC-R2, CXCR-2, CXCR2 gene for IL8 receptor type B, GRO/MGSA receptor, High affinity interleukin-8 receptor B, IL-8 receptor type 2, IL-8R B, IL8R2, IL8RA, interleukin 8 receptor B, interleukin 8 receptor type 2, interleukin-8 receptor type B
NS0 mouse myeloma cell line transfected with human CXCR2/IL-8 RB, Met1-Leu355, Accession # AAB25880
0.1 mL
Angiogenesis, Cancer, Chemokines and Cytokines, Cytokine Research, GPCR, Immunology, Innate Immunity, Myeloid derived Suppressor Cell
3579
Store at 4°C in the dark.
IgG2a
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.